ETF Managers Group, LLC Uro Gen Pharma Ltd. Transaction History

ETF Managers Group, LLC

$2.78 Billion
Q1 2023

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$9.03 - $19.13 $194,686 - $412,442	-21,560 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$14.31 - $18.39 $21,236 - $27,290	-1,484 Reduced 6.44%	21,560 $367,000
Q2 2021 Aug 16, 2021	SELL	$15.2 - $20.94 $253,049 - $348,609	-16,648 Reduced 41.94%	23,044 $367,000
Q1 2021 May 17, 2021	BUY	$17.99 - $26.96 $127,531 - $191,119	7,089 Added 21.74%	39,692 $735,000
Q4 2020 Feb 16, 2021	BUY	$17.54 - $25.43 $68,739 - $99,660	3,919 Added 13.66%	32,603 $590,000

Q3 2020 Nov 16, 2020	BUY	$18.81 - $26.42 $41,946 - $58,916	2,230 Added 8.43%	28,684 $554,000
Q2 2020 Aug 14, 2020	BUY	$16.5 - $29.7 $47,256 - $85,060	2,864 Added 12.14%	26,454 $673,000
Q1 2020 May 14, 2020	BUY	$13.68 - $34.6 $28,673 - $72,521	2,096 Added 9.75%	23,590 $428,000
Q4 2019 Feb 14, 2020	BUY	$21.11 - $34.86 $34,578 - $57,100	1,638 Added 8.25%	21,494 $731,000
Q3 2019 Nov 14, 2019	BUY	$23.83 - $36.44 $51,496 - $78,746	2,161 Added 12.21%	19,856 $476,000
Q2 2019 Aug 14, 2019	BUY	$32.75 - $40.35 $196,008 - $241,494	5,985 Added 51.11%	17,695 $583,000
Q1 2019 May 07, 2019	SELL	$35.47 - $54.55 $13,372 - $20,565	-377 Reduced 3.12%	11,710 $433,000
Q4 2018 Feb 01, 2019	BUY	$38.35 - $50.39 $59,097 - $77,650	1,541 Added 14.61%	12,087 $520,000
Q3 2018 Nov 14, 2018	BUY	$41.65 - $51.7 $439,240 - $545,228	10,546 New	10,546 $498,000
Q2 2018 Aug 14, 2018	SELL	$48.35 - $65.33 $394,584 - $533,158	-8,161 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$38.64 - $57.54 $50,850 - $75,722	1,316 Added 19.23%	8,161 $395,000
Q4 2017 Feb 14, 2018	BUY	$27.28 - $43.26 $186,731 - $296,114	6,845	6,845 $264,000

Others Institutions Holding URGN

# of Institutions

113

Shares Held

24M

Call Options Held

46.9K

Put Options Held

44.3K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $373M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Account